Clinical Trials Browser

Myeloproliferative Disorders, Polycythemia Vera, Primary Myelofibrosis

NCT07445893 2026-03-03

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Phase NA Not yet recruiting

30 enrolled

Myeloid

Polycythemia Vera

NCT07349134 2026-01-20

WELL-MPN

Phase NA Not yet recruiting

75 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07341048 2026-01-15

ACTIVAQ

Phase NA Not yet recruiting

54 enrolled

Myeloid

Polycythemia, Polycythemia Vera

NCT06290765 2025-07-31

PV

Phase 4 Not yet recruiting

70 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT07012109 2025-06-10

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Phase 1 Not yet recruiting

90 enrolled

Myeloid

Polycythemia Vera

NCT06923670 2025-05-15

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Phase NA Not yet recruiting

496 enrolled

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT06785870 2025-01-21

EVEREST

Not yet recruiting

1,500 enrolled

Myeloid

Polycythemia, primary familial and congenital, Disease, Polycythemia, Polycythemia Vera

NCT06251102 2024-05-09

REVIEW

Not yet recruiting

153 enrolled

Myeloid

Polycythemia Vera

Clinical Trials

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

WELL-MPN

ACTIVAQ

PV

Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

EVEREST

REVIEW